AbbVie Fights IRS Nix Of Deduction For $1.6B Merger Fee
By David van den Berg · March 9, 2023, 6:57 PM EST
Pharmaceutical giant AbbVie is challenging the IRS' denial of its claimed deduction for a $1.6 billion break fee payment to Irish biotechnology company Shire over their failed merger, telling the U.S....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login
